Wedbush Securities’s Medifast MED Stock Holding History

Wedbush Securities’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-856	Closed	-$242K	–	1218
2021 Q2	$242K	Buy	+856	New	+$232K	0.01%	972

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Wedbush Securities's MED Position: Q3 2021 in Review

Wedbush Securities sold out of Medifast (MED) in Q3 2021, closing a stake of 856 shares — an estimated $242K sold.

Wedbush Securities first reported a position in MED in Q2 2021 and held it in 1 quarter. The position peaked at $242K in Q2 2021. 296 funds tracked by Wall St. Rank hold MED as of Q3 2021.

Wedbush Securities reported no remaining Medifast position as of Q3 2021 after selling out during the quarter.
Wedbush Securities sold 856 Medifast shares in Q3 2021, an estimated $242K.
Wedbush Securities first reported a position in Medifast in Q2 2021 and held it in 1 quarter.
Wedbush Securities's Medifast position peaked at $242K in Q2 2021.
296 funds tracked by Wall St. Rank held Medifast as of Q3 2021.

Based on Wedbush Securities's 13F filing for Q3 2021, filed 8 Oct 2021.